Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
The company projected 2026 revenue of $2.7 billion to $2.9 billion
Their ability to target both direct (TGF- inhibition) and indirect (metabolic, inflammatory) drivers of fibrosis may provide a powerful, synergistic therapeutic approach
We posited that LLII MOTS-c treatment would cause metabolic reprogramming in old mice
These changes are not pathological but represent your body protecting against what it perceives as starvation
US$ 27.48
US$ 26.16
US$ 25.09
US$ 27.58
US$ 28.99
US$ 29.40
US$ 24.32
US$ 29.34
US$ 22.44
US$ 21.82
.webp)
US$ 23.23
US$ 20.60
US$ 28.19
